Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 34c, Beats on Revenue; Offers FY25 Revenue Guidance

May 7, 2025 4:26 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.68, $0.34 better than the analyst estimate of $0.34. Revenue for the quarter came in at $141.4 million versus the consensus estimate of $131.54 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2025 revenue of $545-565 million, versus the consensus of... More